TCL Archive Clinton Budget Provides 4.7% Increase For NIH; $118 Million Raise for NCI February 11, 1994
TCL Archive Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says July 18, 1986
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion October 5, 2012
